Medicine
Hydrochlorothiazide and Lisinopril 12.5 mg/20 mg tablet
Hydrochlorothiazide and Lisinopril 12.5 mg/20 mg tablet is a generic prescription medicine for oral use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C-25°C (68°F-77°F), excursions permitted to 15°C-30°C (59°F-86°F)…
Key facts
- Active ingredient (INN)
- Hydrochlorothiazide and Lisinopril
- Brand
- Sold under the generic name
- Strength
- 12.5 mg/20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 93 more
- Manufacturers
- Aurobindo PharmaIndiaCiplaIndiaLupinIndiaAphena Pharma Solutions - TennesseeBryant Ranch PrepackExelan PharmaceuticalsSolco HealthcareActavis PharmaGsmsLegacy Pharmaceutical Packaging20 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C-25°C (68°F-77°F), excursions permitted to 15°C-30°C (59°F-86°F). Protect from excessive light and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2003
- Identifiers
- RxCUI 197886, 197885, 197887DailyMed set ID 4510c108-2683-f505-e063-6394a90ab0a4, 52b90789-2902-3ab9-e063-6394a90a5abb, 515f735c-5dba-43d9-8a58-97a319cafd56 +30NDC 72189-651, 67046-0433, 68180-519 +30Application ANDA076230, ANDA077912, ANDA076194 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 20 labelers. The register lists 96 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-044-00 | Aurobindo PharmaIndia | 14 March 2006 |
| 100 tablet in 1 bottle | 65862-044-01 | Aurobindo PharmaIndia | 14 March 2006 |
| 500 tablet in 1 bottle | 65862-044-05 | Aurobindo PharmaIndia | 14 March 2006 |
| 30 tablet in 1 bottle | 65862-044-30 | Aurobindo PharmaIndia | 14 March 2006 |
| 1000 tablet in 1 bottle | 65862-044-99 | Aurobindo PharmaIndia | 14 March 2006 |
| 90 tablet in 1 bottle | 69097-969-05 | CiplaIndia | 26 December 2019 |
| 100 tablet in 1 bottle | 69097-969-07 | CiplaIndia | 26 December 2019 |
| 500 tablet in 1 bottle | 69097-969-12 | CiplaIndia | 26 December 2019 |
| 1000 tablet in 1 bottle | 69097-969-15 | CiplaIndia | 26 December 2019 |
| 100 tablet in 1 bottle | 68180-519-01 | LupinIndia | 4 October 2006 |
| 500 tablet in 1 bottle | 68180-519-02 | LupinIndia | 4 October 2006 |
| 5000 tablet in 1 pouch | 68180-519-30 | LupinIndia | 4 October 2006 |
| 100 tablet in 1 bottle, plastic | 0591-0861-01 | Actavis Pharma | 4 March 2003 |
| 500 tablet in 1 bottle, plastic | 0591-0861-05 | Actavis Pharma | 4 March 2003 |
| 100 tablet in 1 bottle | 76282-447-01 | Exelan Pharmaceuticals | 1 May 2019 |
| 500 tablet in 1 bottle | 76282-447-05 | Exelan Pharmaceuticals | 1 May 2019 |
| 1000 tablet in 1 bottle | 76282-447-10 | Exelan Pharmaceuticals | 1 May 2019 |
| 90 tablet in 1 bottle | 76282-447-90 | Exelan Pharmaceuticals | 1 May 2019 |
| 500 tablet in 1 bottle | 51407-565-05 | Gsms | 15 February 2025 |
| 90 tablet in 1 bottle | 51407-565-90 | Gsms | 15 February 2025 |
| 30 tablet in 1 bottle | 68645-557-54 | Legacy Pharmaceutical Packaging | 10 April 2006 |
| 100 tablet in 1 bottle | 43547-421-10 | Solco Healthcare | 12 March 2015 |
| 1000 tablet in 1 bottle | 43547-421-11 | Solco Healthcare | 12 March 2015 |
| 500 tablet in 1 bottle | 43547-421-50 | Solco Healthcare | 12 March 2015 |
| 180 tablet in 1 bottle, plastic | 71610-274-80 | Aphena Pharma Solutions - Tennessee | 6 May 2019 |
| 90 tablet in 1 bottle | 71610-374-60 | Aphena Pharma Solutions - Tennessee | 13 January 2020 |
| 180 tablet in 1 bottle | 71610-374-80 | Aphena Pharma Solutions - Tennessee | 16 December 2019 |
| 30 tablet in 1 bottle | 71610-838-30 | Aphena Pharma Solutions - Tennessee | 31 May 2024 |
| 60 tablet in 1 bottle | 71610-838-53 | Aphena Pharma Solutions - Tennessee | 31 May 2024 |
| 90 tablet in 1 bottle | 71610-838-60 | Aphena Pharma Solutions - Tennessee | 31 May 2024 |
| 120 tablet in 1 bottle | 71610-838-70 | Aphena Pharma Solutions - Tennessee | 31 May 2024 |
| 180 tablet in 1 bottle | 71610-838-80 | Aphena Pharma Solutions - Tennessee | 31 May 2024 |
| 90 tablet in 1 bottle | 71610-868-60 | Aphena Pharma Solutions - Tennessee | 5 December 2024 |
| 180 tablet in 1 bottle | 71610-868-80 | Aphena Pharma Solutions - Tennessee | 5 December 2024 |
| 30 tablet in 1 bottle | 63629-4470-1 | Bryant Ranch Prepack | 24 March 2011 |
| 90 tablet in 1 bottle | 63629-4470-2 | Bryant Ranch Prepack | 16 May 2011 |
| 100 tablet in 1 bottle | 63629-4470-3 | Bryant Ranch Prepack | 22 December 2021 |
| 60 tablet in 1 bottle | 63629-4470-4 | Bryant Ranch Prepack | 10 February 2015 |
| 360 tablet in 1 bottle | 63629-4470-5 | Bryant Ranch Prepack | 22 December 2021 |
| 4 tablet in 1 bottle | 63629-4470-6 | Bryant Ranch Prepack | 22 December 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 16 February 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Hydrochlorothiazide and Lisinopril 12.5 mg/20 mg tablet.
Other strengths and forms of Hydrochlorothiazide and Lisinopril
Clinical summary
Hydrochlorothiazide and Lisinopril is a fixed-dose combination of an angiotensin converting enzyme inhibitor and a thiazide diuretic indicated for the treatment of hypertension, to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Hydrochlorothiazide and Lisinopril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Hydrochlorothiazide and LisinoprilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zestoretic prescribing information (Almatica Pharma) · U.S. National Library of Medicine, DailyMed
Need Hydrochlorothiazide and Lisinopril 12.5 mg/20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.